| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.2M | -32.7% |
| R&D Expense | $52.0M | +10.4% |
| SG&A Expense | $16.6M | +7.6% |
| Operating Income | -$67.4M | -11.0% |
| Interest Expense | $2K | +0.0% |
| Income Tax | $0 | — |
| Net Income | -$66.1M | -9.2% |
| EPS (Basic) | -$0.92 | +15.6% |
| EPS (Diluted) | -$0.92 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $15.9M | -3.5% |
| Current Assets | $79.8M | -40.2% |
| Total Assets | $110.9M | -36.6% |
| Current Liabilities | $12.1M | +20.3% |
| Stockholders' Equity | $82.6M | -43.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$56.9M | -9.0% |
| Capital Expenditures | $728K | +7.2% |
| Investing Cash Flow | $58.4M | +209.6% |
| Financing Cash Flow | -$2.0M | -102.3% |
| Free Cash Flow | -$57.6M | -9.0% |
| +15.6% |